Literature DB >> 2966694

Effects of aspirin, naloxone and placebo.

A A Mewa1, D Rosenbloom, E M Grace, P Brooks, N Bellamy, C Denko, G Norman, W W Buchanan.   

Abstract

This study was designed to examine the effects of aspirin, naloxone and placebo treatment on serum beta-endorphin concentration and joint pain in patients with rheumatoid arthritis (RA). Ten patients with definite or classical RA were studied. All treatments were administered in a randomized sequence. On each study day, the following measurements were carried out at specified time intervals: serum beta-endorphin concentration, serum salicylate concentration and joint pain score on a visual analogue horizontal scale. We conclude that in patients with rheumatoid arthritis suffering from chronic joint pain, serum beta-endorphin does not appear to play a role in pain relief.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2966694     DOI: 10.1007/bf02330589

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Are the endorphins active in clinical pain states? Narcotic antagonism in chronic pain patients.

Authors:  Ulf Lindblom; Richard Tegnér
Journal:  Pain       Date:  1979-08       Impact factor: 6.961

2.  The influence of naloxone on the C fiber response of dorsal horn neurons and their inhibitory control by raphe magnus stimulation.

Authors:  J P Rivot; A Chaouch; J M Besson
Journal:  Brain Res       Date:  1979-11-02       Impact factor: 3.252

3.  C fragment of lipotropin has a high affinity for brain opiate receptors.

Authors:  N J Birdsall; E C Hulme
Journal:  Nature       Date:  1976-04-29       Impact factor: 49.962

4.  Lack of effect of naloxone on pain perception in humans.

Authors:  A El-Sobky; J O Dostrovsky; P D Wall
Journal:  Nature       Date:  1976-10-28       Impact factor: 49.962

5.  [Abolition by naloxone of the inhibitory effect of peripheral electrical stimulation on the blink reflex].

Authors:  F Boureau; J C Willer; Y Yamaguchi
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1979-09

6.  The narcotic antagonist naloxone enhances clinical pain.

Authors:  J D Levine; N C Gordon; R T Jones; H L Fields
Journal:  Nature       Date:  1978-04-27       Impact factor: 49.962

7.  Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects.

Authors:  P Grevert; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

8.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

Authors:  R Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
Journal:  Science       Date:  1977-09-30       Impact factor: 47.728

9.  Serum beta-endorphin in rheumatic disorders.

Authors:  C W Denko; J Aponte; P Gabriel; M Petricevic
Journal:  J Rheumatol       Date:  1982 Nov-Dec       Impact factor: 4.666

10.  beta-Endorphin in obstetric analgesia.

Authors:  T Oyama; A Matsuki; T Taneichi; N Ling; R Guillemin
Journal:  Am J Obstet Gynecol       Date:  1980-07-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.